Human Cartilage intermediate layer protein 1(CILP) ELISA kit

Code CSB-EL005437HU
Size 96T,5×96T,10×96T
Price Request a Quote
Trial Size 24T ELISA Kit Trial Size (Only USD$150/ kit)
* Sample kit cost can be deducted as a $30 credit for each 96-assay kit of the same analyte and brand you subsequently purchase within six months until depleted. More details >>
Interested in a trial size? Please leave a message below.
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Target Name
cartilage intermediate layer protein, nucleotide pyrophosphohydrolase
Alternative Names
Cartilage intermediate layer protein 1 ELISA Kit; Cartilage intermediate layer protein 1 C1 ELISA Kit; Cartilage intermediate layer protein 1 C2 ELISA Kit; cartilage intermediate layer protein ELISA Kit; cartilage intermediate layer protein; nucleotide pyrophosphohydrolase ELISA Kit; Cartilage intermediate-layer protein ELISA Kit; CILP 1 ELISA Kit; CILP ELISA Kit; CILP-1 ELISA Kit; CILP1_HUMAN ELISA Kit; HGNC:1980 ELISA Kit; HsT18872 ELISA Kit
Abbreviation
CILP
Uniprot No.
Species
Homo sapiens (Human)
Sample Types
serum, plasma, tissue homogenates
Detection Range
93.75 pg/mL-6000 pg/mL
Sensitivity
23.4 pg/mL
Assay Time
1-5h
Sample Volume
50-100ul
Detection Wavelength
450 nm
Research Area
Signal Transduction
Assay Principle
quantitative
Measurement
Sandwich
Precision
Intra-assay Precision (Precision within an assay): CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess.
Inter-assay Precision (Precision between assays): CV%<10%
Three samples of known concentration were tested in twenty assays to assess.
Linearity
To assess the linearity of the assay, samples were spiked with high concentrations of human CILP in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
SampleSerum(n=4)
1:5Average %94
Range %90-98
1:10Average %105
Range %100-112
1:20Average %84
Range %80-88
1:40Average %95
Range %90-100
Recovery
The recovery of human CILP spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
Sample TypeAverage % RecoveryRange
Serum (n=5) 9389-98
EDTA plasma (n=4)9894-106
Typical Data
These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
pg/ml OD1OD2AverageCorrected
60002.098 2.201 2.150 2.027
30001.512 1.454 1.483 1.360
15000.983 0.934 0.959 0.836
7500.611 0.643 0.627 0.504
3750.330 0.338 0.334 0.211
187.50.282 0.302 0.292 0.169
93.750.192 0.207 0.200 0.077
00.125 0.120 0.123
Troubleshooting
and FAQs
Storage
Store at 2-8°C. Please refer to protocol.
Shelf Life
6 months
Lead Time
3-5 working days after you place the order, and it takes another 3-5 days for delivery via DHL or FedEx.
Description

Cartilage intermediate layer protein 1 (CILP) is a secreted glycoprotein found primarily in the intermediate layer of articular cartilage. This protein functions as a nucleotide pyrophosphohydrolase and plays an important role in cartilage matrix organization and maintenance. CILP has been linked to various cartilage-related disorders and osteoarthritis pathogenesis, making it a significant biomarker for joint health research. Its expression levels can offer insights into cartilage metabolism and degenerative processes affecting joint function.

The Human Cartilage intermediate layer protein 1 ELISA kit (CSB-EL005437HU) uses a quantitative sandwich measurement principle for detecting CILP in human samples. This assay works with serum, plasma, and tissue homogenates with a detection range of 93.75 pg/mL to 6000 pg/mL and shows a sensitivity of 23.4 pg/mL. The protocol requires 50-100 μL sample volume and can be completed within 1-5 hours, with detection performed at 450 nm wavelength.

Application Examples

Note: The following application examples are drawn from a selection of publications citing this product. For additional applications, please refer to the full list of references in the "Citations" section.

This ELISA kit has been used in cardiovascular disease research to measure circulating cartilage intermediate layer protein levels in patient populations. Studies have applied the kit to examine biomarker associations in heart failure patients and to compare protein concentrations between different clinical groups. The kit has also been used in dermatological research examining hidradenitis suppurativa patients.

Cardiovascular research: Measuring circulating biomarker levels in heart failure patients with reduced ejection fraction and comparison with control populations
Clinical biomarker studies: Examining protein concentration differences between patient groups and healthy individuals in cardiovascular disease contexts
Dermatological research: Measuring serum protein levels in hidradenitis suppurativa patients to explore disease-associated biomarkers
Comparative assay validation: Testing kit performance alongside other commercial immunoassays to establish measurement correlations and analytical reliability

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

 Q&A
Q:

what part of the protein this ELISA kit targets? As I am aware,
the Cilp gene encodes a precursor that is cleaved into two fragments.
I was curious as to whether this kit targets a specific fragment.

A:
Thanks for your inquiry!
CSB-EL005437HU
This kit is designed according to: https://www.uniprot.org/uniprot/O75339.
It detects CILP protein. The two fragments you mentioned should be C1 and C2. Sorry we are not clear if these 2 forms can be detected out or not. If the fragment is within the antibody's recognition area, then it can be detected out. However, in general the protein has spatial structure, so it is difficult to predict if it can be detected out or not. We suggest you do a pretest first.
Pls let me know if you have any further questions. Thank you.

Target Background

Function
(From Uniprot)
Probably plays a role in cartilage scaffolding. May act by antagonizing TGF-beta1 (TGFB1) and IGF1 functions. Has the ability to suppress IGF1-induced proliferation and sulfated proteoglycan synthesis, and inhibits ligand-induced IGF1R autophosphorylation. May inhibit TGFB1-mediated induction of cartilage matrix genes via its interaction with TGFB1. Overexpression may lead to impair chondrocyte growth and matrix repair and indirectly promote inorganic pyrophosphate (PPi) supersaturation in aging and osteoarthritis cartilage.
Gene References into Functions
  1. CILP rs2073711 TT is associated with increased risk of symmetrical hand osteoarthritis particularly in individuals with low variation in work tasks. PMID: 29233086
  2. Meta-analysis. Our results confirm the positive association between CILP and intervertebral disc degeneration, providing novel clues for clarifying the role of CILP in the development of IVD. PMID: 27359356
  3. CILP is involved in the etiology of intervertebral disc degeneration among young adults. PMID: 22107760
  4. The researchers found that the single nucleotide polymorphism (1184T/C) of the CILP gene is associated an increased risk of lumbar disc degeneration in male athletes. PMID: 20724643
  5. CILP regulates TGF-beta signaling and that this regulation has a crucial role in the etiology and pathogenesis of LDD. PMID: 15864306
  6. These observations, together with the finding that CILP protein binds and inhibits TGF-beta1, suggest that CILP and TGF-beta1 may form a functional feedback loop that controls chondrocyte metabolism. PMID: 16413503
  7. SNP analysis suggested that the CILP gene is not a major risk factor for symptoms of lumbar disc disease in Finnish or Chinese populations. PMID: 17220213
  8. the CILP gene 1184T/C polymorphism is a significant risk factor for lumbar disc degeneration occurrence in Japanese collegiate judo athletes PMID: 19569011

Show More

Hide All

Involvement in disease
Intervertebral disc disease (IDD)
Subcellular Location
Secreted, extracellular space, extracellular matrix.
Tissue Specificity
Specifically expressed in cartilage. Localizes in the intermediates layer of articular cartilage but neither in the superficial nor in the deepest regions. Specifically and highly expressed in intervertebral disk tissue. Expression increases with aging in
Database Links

HGNC: 1980

OMIM: 603489

KEGG: hsa:8483

STRING: 9606.ENSP00000261883

UniGene: Hs.442180

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2025 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1